 preliminari result norwegian doxazosin surveil studi twelve-week experi studi safeti efficaci doxazosin control blood pressur gener medic practic result concern first patient period blood pressur treatment doxazosin mm Hg heart rate addit doxazosin total cholesterol level triglycerid level high-dens lipoprotein cholesterol level high-dens lipoprotein total cholesterol ratio calcul risk coronari heart diseas period thirty-f percent patient side effect number patient sever advers reaction small patient treatment advers event dose doxazosin